Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-01

FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for generic omeprazole from Lannett Company under ANDA075410, authorizing continued marketing under the approved labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)